{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:41:53Z","timestamp":1785840113075,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Jingzhou Central Hospital","award":["201206606"],"award-info":[{"award-number":["201206606"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.06.150","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T17:57:49Z","timestamp":1530381469000},"page":"2286-2292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer"],"prefix":"10.1016","volume":"503","author":[{"given":"Changlei","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.06.150_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbrc.2018.06.150_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.03.025","article-title":"Cancer chemoresistance; biochemical and molecular aspects: a brief overview","volume":"89","author":"Kachalaki","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci. Official J. Eur. Fed. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2018.06.150_bib3","first-page":"1203","article-title":"Targeting the eIF4E\/beta-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy","volume":"9","author":"Xu","year":"2017","journal-title":"Am. J. Tourism Res."},{"issue":"9","key":"10.1016\/j.bbrc.2018.06.150_bib4","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cellsig.2016.06.005","article-title":"Inhibition of MNK pathways enhances cancer cell response to\u00a0chemotherapy with temozolomide and targeted radionuclide therapy","volume":"28","author":"Grzmil","year":"2016","journal-title":"Cell.\u00a0Signal."},{"key":"10.1016\/j.bbrc.2018.06.150_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0959-440X(03)00009-5","article-title":"Eukaryotic translation initiation factors and regulators","volume":"13","author":"Sonenberg","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbrc.2018.06.150_bib6","doi-asserted-by":"crossref","first-page":"18105","DOI":"10.1073\/pnas.0406927102","article-title":"Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap","volume":"101","author":"Kentsis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.06.150_bib7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/sj.onc.1202563","article-title":"Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis","volume":"18","author":"Rosenwald","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.06.150_bib8","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"Lim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.06.150_bib9","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-07-0752","article-title":"Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors","volume":"67","author":"Larsson","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.150_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/10507250152740939","article-title":"Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma","volume":"11","author":"Wang","year":"2001","journal-title":"Thyroid : Official J Am. Thyroid. Assoc"},{"key":"10.1016\/j.bbrc.2018.06.150_bib11","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1182\/blood-2003-07-2193","article-title":"Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells","volume":"103","author":"Kharas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.06.150_bib12","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.18632\/oncotarget.13772","article-title":"Inhibiting the MNK-eIF4E-beta-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.06.150_bib13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/1535-7163.MCT-07-2357","article-title":"eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling","volume":"7","author":"Soni","year":"2008","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.06.150_bib14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.biopha.2017.10.034","article-title":"Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy","volume":"96","author":"Wang","year":"2017","journal-title":"Biomed pharmacother\u00a0= Biomed pharmacotherapie"},{"key":"10.1016\/j.bbrc.2018.06.150_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3109\/10428194.2010.496506","article-title":"Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?","volume":"51","author":"Borden","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2018.06.150_bib16","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-10-2334","article-title":"Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer","volume":"17","author":"Pettersson","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.150_bib17","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1005320107","article-title":"eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression","volume":"107","author":"Furic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.06.150_bib18","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Wendel","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2018.06.150_bib19","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1158\/0008-5472.CAN-04-2677","article-title":"Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities","volume":"64","author":"Topisirovic","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.150_bib20","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","article-title":"eIF4E\u2013from translation to transformation","volume":"23","author":"Mamane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.06.150_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4161\/cbt.10.7.12965","article-title":"The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival","volume":"10","author":"Wheater","year":"2010","journal-title":"Canc. Biol. Ther."},{"issue":"3","key":"10.1016\/j.bbrc.2018.06.150_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cgh.2016.10.034","article-title":"Identification of the best direct-acting antiviral regimen for patients with hepatitis C virus genotype 3 infection: a systematic review and network meta-analysis","volume":"15","author":"Berden","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol. : The Official Clinical Practice Journal of the American Gastroenterological Association"},{"key":"10.1016\/j.bbrc.2018.06.150_bib23","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.02349-15","article-title":"Investigating the influence of ribavirin on human respiratory syncytial virus RNA synthesis by using a high-resolution transcriptome sequencing approach","volume":"90","author":"Aljabr","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2018.06.150_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2009-02-205153","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"Assouline","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.06.150_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2867-14-63","article-title":"Anti-tumor effect of ribavirin in combination with interferon-alpha on renal cell carcinoma cell lines in\u00a0vitro","volume":"14","author":"Teng","year":"2014","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.bbrc.2018.06.150_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.prp.2017.02.004","article-title":"Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma","volume":"213","author":"Chen","year":"2017","journal-title":"Pathol. Research and Practice"},{"key":"10.1016\/j.bbrc.2018.06.150_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123352","article-title":"Phosphorylation of eIF4E confers resistance to cellular stress and DNA-damaging agents through an interaction with 4E-t: a rationale for novel therapeutic approaches","volume":"10","author":"Martinez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.06.150_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13572","article-title":"eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies","volume":"513","author":"Boussemart","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.06.150_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbrc.2016.12.025","article-title":"Inhibition of mTOR\/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma","volume":"482","author":"Dai","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.06.150_bib30","article-title":"Ribavirin inhibits the activity of mTOR\/eIF4E, ERK\/mnk1\/eIF4E signaling pathway and synergizes with tyrosine kinase inhibitor imatinib to impair Bcr-abl mediated proliferation and apoptosis in Ph+ leukemia","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.06.150_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/leu.2011.57","article-title":"Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens","volume":"25","author":"Kraljacic","year":"2011","journal-title":"Leukemia"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:14:57Z","timestamp":1604506497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18314694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18314694"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.150","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}